{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:54:16Z","timestamp":1790013256801,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd003262.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T00:00:00Z","timestamp":1430179200000}}],"reference-count":329,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003262.pub5","type":"journal-article","created":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T17:52:42Z","timestamp":1430243562000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Interventions for rosacea"],"prefix":"10.1002","volume":"2017","author":[{"given":"Esther J","family":"van Zuuren","sequence":"first","affiliation":[{"name":"Leiden University Medical Center; Department of Dermatology; PO Box 9600 B1-Q Leiden Netherlands 2300 RC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbys","family":"Fedorowicz","sequence":"additional","affiliation":[{"name":"Cochrane; Bahrain Branch; Box 25438 Awali Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Carter","sequence":"additional","affiliation":[{"name":"King's College London; Institute of Psychiatry, Psychology & Neuroscience; Biostatistics and Health Informatics; Denmark Hill London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille MD","family":"van der Linden","sequence":"additional","affiliation":[{"name":"Academic Medical Center; Department of Dermatology; P.O. Box 22660 Amsterdam Netherlands 1100 DD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn","family":"Charland","sequence":"additional","affiliation":[{"name":"The University of Nottingham; c\/o Cochrane Skin Group; Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,4,28]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-4632.2008.03445.x","article-title":"Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial","volume":"47","author":"Akhyani","year":"2008","journal-title":"International Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaad.2013.04.015","article-title":"Comparative effectiveness of nonpurpuragenic 595-nm pulsed dye laser and microsecond 1064-nm neodymium:yttrium-aluminum-garnet laser for treatment of diffuse facial erythema: A double-blind randomized controlled trial","volume":"69","author":"Alam","year":"2013","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archderm.135.6.659","article-title":"Effect of treatment of Helicobacter pylori infection on rosacea","volume":"135","author":"Bamford","year":"1999","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0005|cit4","first-page":"S41","article-title":"Rosacea unresponsive to oral zinc sulfate, a randomized controlled clinical trial","volume":"129 Suppl 1","author":"Bamford","year":"2009","journal-title":"Journal of Investigative Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0004|cit5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-4632.2011.05353.x","article-title":"Randomized, double-blind trial of 220 mg zinc sulfate twice daily in the treatment of rosacea","volume":"51","author":"Bamford","year":"2012","journal-title":"International Journal of Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD003262.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/S0161-6420(96)30412-0","article-title":"The efficacy of topical metronidazole in the treatment of ocular rosacea","volume":"103","author":"Barnhorst","year":"1996","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/bjd.12881","article-title":"Comparative pharmacokinetics and bioavailability of brimonidine following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate-to-severe facial erythema associated with rosacea","volume":"171","author":"Benkali","year":"2014","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1473-2165.2011.00598.x","article-title":"Clinical and instrumental assessment of the effects of a new product based on hydroxypropyl chitosan and potassium azeloyl diglycinate in the management of rosacea","volume":"11","author":"Berardesca","year":"2012","journal-title":"Journal of Cosmetic Dermatology"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD003262.pub5-BIB0009|cit9","first-page":"P10","article-title":"A multi-center, investigator-blind clinical trial to assess the safety and efficacy of metronidazole gel 1% as compared to metronidazole gel vehicle and metronidazole cream 1% in the treatment of rosacea","volume":"52","author":"Beutner","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/BF03259203","article-title":"A double-blind randomised study of metronidazole (Flagyl) 1% cream in the treatment of acne rosacea, a placebo controlled study","volume":"2","author":"Bitar","year":"1990","journal-title":"Drug Investigation"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0011|cit11","first-page":"187","article-title":"Metronidazole (Elyzol) 1% cream v. placebo cream in the treatment of rosacea","volume":"26","author":"Bjerke","year":"1989","journal-title":"Clinical Trials Journal"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/000155599750009906","article-title":"Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea","volume":"79","author":"Bjerke","year":"1999","journal-title":"Acta Dermato-Venerologica"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archderm.1987.01660290077020","article-title":"Topical metronidazole therapy for rosacea","volume":"123","author":"Bleicher","year":"1987","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2340\/0001555564358359","article-title":"Topical treatment with sulfur 10 per cent for rosacea","volume":"64","author":"Blom","year":"1984","journal-title":"Acta Dermato-Venereologica"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0015|cit15","first-page":"44","article-title":"A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea","volume":"61","author":"Breneman","year":"1998","journal-title":"Cutis"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-4632.2004.02283.x","article-title":"Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide\/clindamycin topical gel in the treatment of moderate to severe rosacea","volume":"43","author":"Breneman","year":"2004","journal-title":"International Journal of Dermatology"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD003262.pub5-BIB0017|cit17","first-page":"11","article-title":"Photographic review of results from a clinical study comparing benzoyl peroxide 5%\/Clindamycin 1% topical gel with vehicle in the treatment of rosacea","volume":"73","author":"Leyden","year":"2004","journal-title":"Cutis"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0018|cit18","doi-asserted-by":"crossref","unstructured":"Bribeche MR Fedotov VP Gladichev VV Pukhalskaya DM Kolitcheva NL Clinical and experimental assessment of the effects of a new topical treatment with praziquantel in the management of rosacea International Journal of Dermatology 2015 481 7 10.1111\/ijd.12552","DOI":"10.1111\/ijd.12552"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0019|cit19","first-page":"43","article-title":"Skin barrier function assessment by in vivo confocal microscopy and other non-invasive optical measurements on patients suffering from rosacea to evaluate the efficacy of a post-laser serum","volume":"45 Suppl 25","author":"Buendia-Bordera","year":"2013","journal-title":"Lasers in Surgery and Medicine"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD003262.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.3109\/09546639309082150","article-title":"Topical azelaic acid in the treatment of rosacea","volume":"4","author":"Carmichael","year":"1993","journal-title":"Journal of Dermatological Treatment"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0021|cit21","first-page":"333","article-title":"A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks","volume":"11","author":"Chang","year":"2012","journal-title":"Journal of Drugs in Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archderm.134.6.679","article-title":"Topical metronidazole maintains remissions of rosacea","volume":"134","author":"Dahl","year":"1998","journal-title":"Archives of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1067\/mjd.2001.116219","article-title":"Once-daily topical metronidazole cream formulations in the treatment of papules and pustules of rosacea","volume":"45","author":"Dahl","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2006.11.021","article-title":"Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea","volume":"56","author":"Rosso","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2006.11.021","article-title":"Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea","volume":"56","author":"Rosso","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0026|cit26","first-page":"A7","article-title":"Comparison of anti-inflammatory dose doxycycline (30-mg immediate-release beads, 10 mg delayed-release beads)vs antibiotic dose doxycycline (100mg) in the treatment of rosacea. 36th Annual Hawaii Dermatology Seminar of the Skin Disease Education Foundation Waikoloa, HI United States, 20120219 Conference End: 20120224","volume":"31","author":"Rosso","year":"2012","journal-title":"Seminars in Cutaneous Medicine and Surgery"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0027|cit27","first-page":"573","article-title":"Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea","volume":"7","author":"Rosso","year":"2008","journal-title":"Journal of Drugs in Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0028|cit28","first-page":"607","article-title":"Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea","volume":"9","author":"Rosso","year":"2010","journal-title":"Journal of Drugs in Dermatology"},{"issue":"7 Pt 2","key":"10.1002\/14651858.CD003262.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1524-4725.2005.31735","article-title":"Efficacy of 1% 4-ethoxybenzaldehyde in reducing facial erythema","volume":"31","author":"Draelos","year":"2005","journal-title":"Dermatologic Surgery"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1473-2165.2006.00219.x","article-title":"An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients","volume":"5","author":"Draelos","year":"2006","journal-title":"Journal of Cosmetic Dermatology"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD003262.pub5-BIB0031|cit31","first-page":"AB82","article-title":"Facial foundation with niacinamide and N-acetylglucosamine improves skin condition in women with sensitive skin","volume":"60","author":"Draelos","year":"2009","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0032|cit32","first-page":"306","article-title":"Azelaic acid foam 15% in the treatment of papulopustular rosacea: a randomized, double-blind, vehicle-controlled study","volume":"92","author":"Draelos","year":"2013","journal-title":"Cutis; Cutaneous Medicine for the Practitioner"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jocd.12061","article-title":"Hydrophobically modified polymers can minimize skin irritation potential caused by surfactant-based cleansers","volume":"12","author":"Draelos","year":"2013","journal-title":"Journal of Cosmetic Dermatology"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD003262.pub5-BIB0034|cit34","first-page":"AB66","article-title":"Tolerance of facial cleansers on adults with clinically sensitive skin","volume":"68","author":"Hornby","year":"2013","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD003262.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/S0926-9959(98)95615-X","article-title":"Comparison of the clinical efficacy and safety of metronidazole 0.75% cream with metronidazole 0.75% gel in the treatment of rosacea","volume":"11","author":"Dreno","year":"1998","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"11","key":"10.1002\/14651858.CD003262.pub5-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/archderm.139.11.1444","article-title":"A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial","volume":"139","author":"Elewski","year":"2003","journal-title":"Archives of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archderm.1994.01690030051008","article-title":"A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea","volume":"130","author":"Ertl","year":"1994","journal-title":"Archives of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0038|cit38","first-page":"129","article-title":"Double-blind study versus excipient of 0.75% metronidazole gel in the treatment of rosacea","volume":"120","author":"Espagne","year":"1993","journal-title":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0039|cit39","first-page":"968","article-title":"Combination 15% azelaic acid gel and intense pulse light therapy for mild to moderate rosacea. 31st Annual Conference of the American Society for Laser Medicine and Surgery, ASLMS 2011 Grapevine, TX United States. Conference Start: 20110330 Conference End: 20110403","volume":"43 Suppl 23","author":"Fabi","year":"2011","journal-title":"Lasers in Surgery & Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0040|cit40","first-page":"641","article-title":"Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea","volume":"6","author":"Fowler","year":"2007","journal-title":"Journal of Drugs in Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2011.10716.x","article-title":"Once-daily topical brimonidine tartrate gel 0\u00b75% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies","volume":"166","author":"Fowler","year":"2012","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0042|cit42","first-page":"48","article-title":"A single application of brimonidine tartrate gel significantly reduces moderate to severe facial erythema of rosacea. 46th Annual Scientific Meeting of the Australasian College of Dermatologists Sydney, NSW Australia. Conference Start: 20130519 Conference End: 20130522","volume":"54 Suppl 2","author":"Meadows","year":"2013","journal-title":"Australasian Journal of Dermatology"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD003262.pub5-BIB0043|cit43","first-page":"AB41","article-title":"A single application of brimonidine tartrate gel significantly reduces moderate to severe facial erythema associated with rosacea. 70th Annual Meeting of the American Academy of Dermatology San Diego, CA United States. Conference Start: 20120316 Conference End: 20120320","volume":"66","author":"Meadows","year":"2012","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2011.10716.x","article-title":"Once-daily topical brimonidine tartrate gel 0\u00b75% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies","volume":"166","author":"Fowler","year":"2012","journal-title":"British Journal of Dermatology"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD003262.pub5-BIB0046|cit45","first-page":"AB17","article-title":"Once-daily topical brimonidine tartrate gel 0.5% is safe and efficacious in the treatment of moderate to severe persistent facial erythema associated with rosacea. 70th Annual Meeting of the American Academy of Dermatology San Diego, CA United States. Conference Start: 20120316 Conference End: 20120320","volume":"66","author":"Fowler","year":"2012","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0045|cit46","first-page":"48","article-title":"Once-daily topical brimonidine tartrate gel 0.5% is safe and efficacious in the treatment of moderate to severe persistent facial erythema of rosacea. 46th Annual Scientific Meeting of the Australasian College of Dermatologists Sydney, NSW Australia. Conference Start: 20130519 Conference End: 20130522","volume":"54 Suppl 2","author":"Fowler","year":"2013","journal-title":"Australasian Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0047|cit47","first-page":"650","article-title":"Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies","volume":"12","author":"Fowler","year":"2013","journal-title":"Journal of Drugs in Dermatology"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0048|cit48","first-page":"49","article-title":"Efficacy and safety of once-daily brimonidine tartrate gel 0.5% for moderate to severe facial erythema of rosacea - Two randomized, double-blind and vehicle controlled Phase III studies. 46th Annual Scientific Meeting of the Australasian College of Dermatologists Sydney, NSW Australia. Conference Start: 20130519 Conference End: 20130522","volume":"54 Suppl 2","author":"Fowler","year":"2013","journal-title":"Australasian Journal of Dermatology"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD003262.pub5-BIB0049|cit49","first-page":"AB15","article-title":"Efficacy and safety of once-daily brimonidine tartrate gel 0.5% for moderate to severe facial erythema of rosacea: Two randomized, double-blind,and vehicle-controlled phase III studies. 71st Annual Meeting of the American Academy of Dermatology Miami Beach, FL United States. Conference Start: 20130301 Conference End: 20130305","volume":"68","author":"Fowler","year":"2013","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0050|cit50","first-page":"699","article-title":"Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosacea","volume":"13","author":"Jackson","year":"2014","journal-title":"Journal of Drugs in Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0051|cit51","first-page":"650","article-title":"Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies","volume":"12","author":"Fowler","year":"2013","journal-title":"Journal of Drugs in Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0052|cit52","first-page":"699","article-title":"Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosacea","volume":"13","author":"Jackson","year":"2014","journal-title":"Journal of Drugs in Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD003262.pub5-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1610-0387.2010.07345.x","article-title":"Systemic isotretinoin in the treatment of rosacea - doxycycline - and placebo-controlled, randomized clinical study","volume":"8","author":"Gollnick","year":"2010","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD003262.pub5-BIB0054|cit54","first-page":"AB41","article-title":"Double-blind, double-dummy, randomized, placebo-controlled, five armed,multicenter phase II\/III study to evaluate the efficacy and safety of different concentrations of isotretinoin versus doxycycline in the treatment of rosacea, subtype II and III. 68th Annual Meeting of the American Academy of Dermatology, AAD Miami, FL United States. Conference Start: 20100305 Conference End: 20100309","volume":"62","author":"Gollnick","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD003262.pub5-BIB0055|cit55","first-page":"687","article-title":"Rilmenidine in rosacea: a double blind study versus placebo","volume":"124","author":"Grosshans","year":"1997","journal-title":"Annales de Dermatologie et Venereologie"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD003262.pub5-BIB0056|cit56","first-page":"S145","article-title":"Metronidazole 0.75% gel and lotion are both effective in the treatment of rosacea","volume":"12","author":"Guillet","year":"1999","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0057|cit57","first-page":"308","article-title":"Clinical research of topical tacrolimus ointment combined with 585 nm pulsed dye laser in the treatment of rosacea [Chinese]","volume":"41","author":"Huang","year":"2012","journal-title":"Journal of Clinical Dermatology"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0058|cit58","first-page":"S181","article-title":"Surface cathelicidin expression is a predictor of treatment success in papulopustular rosacea. 2013 International Investigative Dermatology Meeting Edinburgh United Kingdom. Conference Start: 20130508 Conference End: 20130511","volume":"133 Suppl 1","author":"Huang","year":"2013","journal-title":"Journal of Investigative Dermatology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD003262.pub5-BIB0059|cit59","first-page":"AB9","article-title":"Multicenter, randomized, double-blind, placebo-controlled evaluation of rosacea related inflammatory biomarkers in papulopustular rosacea adults treated with doxycycline 40 mg modified release. 72nd Annual Meeting of the American Academy of Dermatology Denver, CO United States. Conference Start: 20140321 Conference End: 20140325","volume":"70","author":"Huang","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0060|cit60","first-page":"292","article-title":"Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea","volume":"12","author":"Jackson","year":"2013","journal-title":"Journal of Drugs in Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0190-9622(98)70337-8","article-title":"The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double blind clinical trial","volume":"39","author":"Jorizzo","year":"1998","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0062|cit62","first-page":"702","article-title":"Treatment of facial telangiectasia using a dual-wavelength laser system (595 and 1,064 nm): a randomized controlled trial with blinded response evaluation","volume":"34","author":"Karsai","year":"2008","journal-title":"Dermatologic Surgery"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"A181","DOI":"10.1016\/j.jval.2014.03.1059","article-title":"A comparison of 3 assessments in the treatment of rosacea in the context of a comparative effectiveness study. ISPOR 19th Annual International Meeting Montreal, QC Canada. Conference Start: 20140531 Conference End: 20140604","volume":"17","author":"Kendall","year":"2014","journal-title":"Value in Health"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0064|cit64","doi-asserted-by":"crossref","unstructured":"Kim TG Roh HJ Cho SB Lee JH Lee SJ Oh SH Enhancing effect of pretreatment with topical niacin in the treatment of rosacea-associated erythema by 585-nm pulsed dye laser in Koreans: A randomized, prospective, split-face trial British Journal of Dermatology 2011 510 3 10.1111\/j.1365-2133.2010.10174.x.","DOI":"10.1111\/j.1365-2133.2010.10174.x"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2230.2009.03427.x","article-title":"A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial","volume":"35","author":"Koca","year":"2010","journal-title":"Clinical and Experimental Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000065849","article-title":"Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea","volume":"205","author":"Ko\u00e7ak","year":"2002","journal-title":"Dermatology"},{"issue":"32 Suppl","key":"10.1002\/14651858.CD003262.pub5-BIB0067|cit67","first-page":"S143","article-title":"Dark sulfonated shale oil versus placebo in the systemic treatment of rosacea [P-011]","volume":"12","author":"Koch","year":"1999","journal-title":"Journal of the European Academy of Dermatology and Venerology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0068|cit68","first-page":"183","article-title":"The comparative efficacy of sodium sulfacetamide 10%\/sulfur 5% (Sulfacet-R) lotion and metronidazole 0.75% (Metrogel) in the treatment of rosacea","volume":"3","author":"Lebwohl","year":"1995","journal-title":"Journal of Geriatric Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD003262.pub5-BIB0069|cit69","first-page":"1179","article-title":"Efficacy of a novel rosacea treatment system: an investigator-blind, randomized, parallel-group study","volume":"10","author":"Leyden","year":"2011","journal-title":"Journal of Drugs in Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0070|cit70","first-page":"685","article-title":"Randomized, phase 2, dose-ranging study in the treatment of rosacea with encapsulated benzoyl peroxide gel","volume":"13","author":"Leyden","year":"2014","journal-title":"Journal of Drugs in Dermatology"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0071|cit71","doi-asserted-by":"crossref","unstructured":"Luger T Peukert N Rother M A multicentre, randomized, placebo-controlled trial establishing the treatment effect of TDT 068, a topical formulation containing drug-free ultra-deformable phospholipid vesicles, on the primary features of erythematotelangiectatic rosacea Journal of the European Academy of Dermatology and Venereology 2015 283 90 10.1111\/jdv.12520","DOI":"10.1111\/jdv.12520"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD003262.pub5-BIB0072|cit72","first-page":"AB43","article-title":"Evaluation of the safety and effectiveness of microfocused ultrasound with visualization (MFU-V) for the treatment of erythematotelangiectatic rosacea. 72nd Annual Meeting of the American Academy of Dermatology Denver, CO United States. Conference Start: 20140321 Conference End: 20140325","volume":"70","author":"Lupin","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD003262.pub5-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0190-9622(99)70085-X","article-title":"A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea","volume":"40","author":"Maddin","year":"1999","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"7733","key":"10.1002\/14651858.CD003262.pub5-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(71)90376-X","article-title":"Comparative effectiveness of tetracycline and ampicillin in rosacea: a controlled trial","volume":"2","author":"Marks","year":"1971","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09546639109092728","article-title":"Topical metronidazole in the treatment of rosacea","volume":"2","author":"Monk","year":"1991","journal-title":"Journal of Dermatological Treatment"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0076|cit76","first-page":"185","article-title":"Topical treatment of acne rosacea with benzoyl peroxide acetone gel","volume":"32","author":"Montes","year":"1983","journal-title":"Cutis"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1468-3083.2008.02940.x","article-title":"Comparative study of some treatment modalities of rosacea","volume":"23","author":"Mostafa","year":"2009","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0078|cit78","unstructured":"NCT00249782 A phase II, randomized, partial-blind, parallel-group, active- and vehicle-controlled, multicenter study of the safety and efficacy of ACZONE\u2122 (dapsone) gel, 5% in subjects with papulopustular rosacea http:\/\/clinicaltrials.gov\/ct\/show\/NCT00249782"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0079|cit79","unstructured":"NCT01426269 Evaluation of relapse, efficacy and safety of long-term treatment with Oracea\u00ae capsules compared to placebo after an initial 12 week treatment regimen with Oracea\u00ae and MetroGel\u00ae 1% in adults with rosacea clinicaltrials.gov\/show\/NCT01426269"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0080|cit80","unstructured":"NCT01449591 A proof of concept (PoC) study to evaluate the safety, tolerability, and efficacy of 12 week administration of BFH772 ointment in rosacea patients clinicaltrials.gov\/show\/NCT01449591"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0081|cit81","unstructured":"NCT01885000 Patient-Reported Outcome of facial erythema (PROOF) clinicaltrials.gov\/show\/NCT01885000"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1524-4725.2009.01156.x","article-title":"Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea","volume":"35","author":"Neuhaus","year":"2009","journal-title":"Dermatologic Surgery"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2133.1983.tb03972.x","article-title":"Treatment of rosacea with 1% metronidazole cream. A double-blind study","volume":"108","author":"Nielsen","year":"1983","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2133.1983.tb03993.x","article-title":"A double-blind study of 1% metronidazole cream versus systemic oxytetracycline therapy for rosacea","volume":"109","author":"Nielsen","year":"1983","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1468-3083.2009.03357.x","article-title":"Long-pulsed dye laser vs. intense pulsed light for the treatment of facial telangiectasias: A randomized controlled trial","volume":"24","author":"Nymann","year":"2010","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"7971","key":"10.1002\/14651858.CD003262.pub5-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(76)92160-7","article-title":"Treatment of rosacea by metronidazole","volume":"1","author":"Pye","year":"1976","journal-title":"Lancet"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD003262.pub5-BIB0087|cit87","first-page":"AB64","article-title":"A double-blind, placebo-controlled study of a natural anti-inflammatory for treatment of rosacea","volume":"54","author":"Rehmus","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1468-3083.2005.01248.x","article-title":"Randomized placebo-controlled trial of a flavonoid-rich plant extract-based cream in the treatment of rosacea","volume":"19","author":"Rigopoulos","year":"2005","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0089|cit89","first-page":"126","article-title":"A comparative, double-blind study about efficacy and safety of crotamiton vs benzyl benzoate in the treatment of rosacea with demodecidosis","volume":"47","author":"Rodr\u00edguez Acar","year":"2003","journal-title":"Dermatolog\u00eda Revista Mexicana"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2133.1980.tb06558.x","article-title":"A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea","volume":"102","author":"Saihan","year":"1980","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijid.2012.11.022","article-title":"Evaluation of the efficacy of oral ivermectin in comparison with ivermectin-metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum","volume":"17","author":"Salem","year":"2013","journal-title":"International Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2005.04.069","article-title":"A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea","volume":"53","author":"Sanchez","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaad.2003.10.192","article-title":"Combined effect of doxycycline hyclate 20 mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea","volume":"50","author":"Sanchez","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/09546639709160276","article-title":"The treatment of rosacea: the safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion (Novacet) is demonstrated in a double-blind study","volume":"8","author":"Sauder","year":"1997","journal-title":"Journal of Dermatological Treatment"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF03259568","article-title":"Comparison of metronidazole 1% cream versus oral tetracycline in patients with rosacea","volume":"3","author":"Schachter","year":"1991","journal-title":"Drug Investigation"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12325-009-0037-2","article-title":"Efficacy of topical cyclosporine for the treatment of ocular rosacea","volume":"26","author":"Schechter","year":"2009","journal-title":"Advances in Therapy"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub5-BIB0097|cit97","first-page":"920","article-title":"Management of rosacea-prone skin: evaluation of a skincare product containing Ambophenol, Neurosensine, and La Roche-Posay Thermal spring water as monotherapy or adjunctive therapy","volume":"12","author":"Seit\u00e9","year":"2013","journal-title":"Journal of Drugs in Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD003262.pub5-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1365-4632.2006.02944.x","article-title":"Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study","volume":"45","author":"Sharquie","year":"2006","journal-title":"International Journal of Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD003262.pub5-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2133.1966.tb12168.x","article-title":"A clinical trial of tetracycline in rosacea","volume":"78","author":"Sneddon","year":"1966","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0100|cit100","first-page":"316","article-title":"Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies","volume":"13","author":"Stein","year":"2014","journal-title":"Journal of Drugs in Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0101|cit101","first-page":"316","article-title":"Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies","volume":"13","author":"Stein","year":"2014","journal-title":"Journal of Drugs in Dermatology"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0102|cit102","doi-asserted-by":"crossref","unstructured":"Taieb A Ortonne JP Ruzicka T Roszkiewicz J Berth-Jones J Peirone MH Superiority of ivermectin 1% cream over metronidazole 0.75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial British Journal of Dermatology 2015 1103 10","DOI":"10.1111\/bjd.13408"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0103|cit103","first-page":"529","article-title":"Randomized placebo-controlled trial of metronidazole 1% cream with sunscreen SPF 15 in treatment of rosacea","volume":"6","author":"Tan","year":"2002","journal-title":"Journal of Cutaneous Medicine and Surgery"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1067\/mjd.2003.308","article-title":"Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: Results from 2 vehicle-controlled, randomized phase III studies","volume":"48","author":"Thiboutot","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1067\/mjd.2003.308","article-title":"Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: Results from 2 vehicle-controlled, randomized phase III studies","volume":"48","author":"Thiboutot","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD003262.pub5-BIB0106|cit106","first-page":"17","article-title":"Efficacy and safety of subantimicrobial-dose doxycycline for the treatment of rosacea","volume":"52","author":"Thiboutot","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0107|cit107","first-page":"541","article-title":"Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea","volume":"7","author":"Thiboutot","year":"2008","journal-title":"Journal of Drugs in Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD003262.pub5-BIB0108|cit108","first-page":"639","article-title":"A Multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance therapy","volume":"8","author":"Thiboutot","year":"2009","journal-title":"Journal of Drugs in Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1248\/cpb.60.583","article-title":"Preparation and evaluation of topical microemulsion system containing metronidazole for remission in rosacea","volume":"60","author":"Tirnaksiz","year":"2012","journal-title":"Chemical & Pharmaceutical Bulletin"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0110|cit110","first-page":"357","article-title":"Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea","volume":"75","author":"Torok","year":"2005","journal-title":"Cutis"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/jid.2013.472","article-title":"Reduction in serine protease activity correlates with improved rosacea severity in a small, randomized pilot study of a topical serine protease inhibitor","volume":"134","author":"Two","year":"2014","journal-title":"Journal of Investigative Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1468-3083.1997.tb00469.x","article-title":"Treatment of rosacea with ketoconazole","volume":"8","author":"Uta\u015f","year":"1997","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"10","key":"10.1002\/14651858.CD003262.pub5-BIB0113|cit113","first-page":"729","article-title":"Treatment of rosacea. Clonidine (0.075 mg per day) versus placebo (initial results)","volume":"124","author":"Landuyt","year":"1997","journal-title":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0114|cit114","first-page":"209","article-title":"Topical metronidazole in the treatment of rosacea","volume":"38","author":"Veien","year":"1986","journal-title":"Cutis"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0115|cit115","first-page":"472","article-title":"Comparative study of topical erythromycin and topical metronidazole in the treatment of rosacea","volume":"9","author":"Verea Hernando","year":"1992","journal-title":"Farmacia Clinica"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1365-2133.2006.07669.x","article-title":"Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial","volume":"156","author":"Weissenbacher","year":"2007","journal-title":"British Journal of Dermatology"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD003262.pub5-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0190-9622(89)70022-0","article-title":"Effect of nadolol on flushing reactions in rosacea","volume":"20","author":"Wilkin","year":"1989","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0118|cit118","first-page":"176","article-title":"Double blind, parallel study of efficacy and safety of clindamycin lotion in the treatment of rosacea","volume":"41","author":"Witt","year":"1987","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-4362.1993.tb00974.x","article-title":"Treatment of rosacea: topical clindamycin versus oral tetracycline","volume":"32","author":"Wilkin","year":"1993","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0120|cit120","first-page":"E-Abstract 2846","article-title":"Efficacy of cyclosporine a for the treatment of ocular rosacea","volume":"46","author":"Wittpenn","year":"2005","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD003262.pub5-BIB0121|cit121","first-page":"3","article-title":"Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea","volume":"77","author":"Wolf","year":"2006","journal-title":"Cutis"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0122|cit122","first-page":"918","article-title":"Combination therapy for the treatment of erythematotelangiectatic rosacea","volume":"43 Suppl 23","author":"Yoo","year":"2011","journal-title":"Lasers in Surgery & Medicine"},{"issue":"23","key":"10.1002\/14651858.CD003262.pub5-BIB0123|cit123","first-page":"1490","article-title":"Acne rosacea: Efficacy of a metronidazole cream","volume":"12","author":"Aitken","year":"1983","journal-title":"Presse M\u00e9dicale"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1346-8138.1992.tb03227.x","article-title":"Oral spironolactone therapy in male patients with rosacea","volume":"19","author":"Aizawa","year":"1992","journal-title":"Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-4632.2004.02130.x","article-title":"Adalapene vs. metronidazole gel for the treatment of rosacea","volume":"44","author":"Altinyazar","year":"2005","journal-title":"International Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/106002808702100410","article-title":"Evaluation of topical metronidazole gel in acne rosacea","volume":"21","author":"Aronson","year":"1987","journal-title":"Drug Intelligence & Clinical Pharmacy"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD003262.pub5-BIB0127|cit127","first-page":"AB24","article-title":"Acne rosacea: an open comparative trial of azithromycin versus oxytetracycline therapy: study of 50 patients [P139]","volume":"54","author":"Bakar","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"19 Suppl","key":"10.1002\/14651858.CD003262.pub5-BIB0128|cit128","first-page":"65","article-title":"Treatment of rosacea with photopnematic therapy [212]","volume":"39","author":"Bang Soon","year":"2007","journal-title":"Lasers in Surgery & Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/bjo.66.6.386","article-title":"Oxytetracycline in the treatment of ocular rosacea: a double-blind trial","volume":"66","author":"Bartholomew","year":"1982","journal-title":"British Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1473-2165.2008.00355.x","article-title":"Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: clinical and instrumental evaluation","volume":"7","author":"Berardesca","year":"2008","journal-title":"Journal of Cosmetic Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0131|cit131","first-page":"55","article-title":"Perolen cream for therapy of rosacea","volume":"120","author":"Beridze","year":"2005","journal-title":"Georgian Medical News"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2133.1982.tb00290.x","article-title":"Alcohol-induced rosacea flushing blocked by naloxone","volume":"107","author":"Bernstein","year":"1982","journal-title":"British Journal of Dermatology"},{"issue":"23","key":"10.1002\/14651858.CD003262.pub5-BIB0133|cit133","first-page":"2295","article-title":"Rosacea. Clinical features and treatment","volume":"109","author":"Bjerke","year":"1989","journal-title":"Tidsskrift for den Norske Laegeforening"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0134|cit134","first-page":"185","article-title":"Treatment of Helicobacter pylori infection in the management of rosacea","volume":"6","author":"Bukvic-Mokos","year":"1998","journal-title":"Acta Dermatovenerologica Croatica"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2133.2005.06404.x","article-title":"The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea","volume":"152","author":"Chu","year":"2005","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0136|cit136","first-page":"317","article-title":"Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15%","volume":"79","author":"Col\u00f3n","year":"2007","journal-title":"Cutis"},{"issue":"6053","key":"10.1002\/14651858.CD003262.pub5-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/bmj.1.6053.105","article-title":"Clonidine and facial flushing in rosacea","volume":"1","author":"Cunliffe","year":"1977","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaad.2003.11.022","article-title":"The use of topical azelaic acid 15% gel or metronidazole 0.75% gel for the treatment of rosacea: Evaluation of a single-site comparative trial subset","volume":"50","author":"Rosso","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD003262.pub5-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1346-8138.2005.tb00874.x","article-title":"Azithromycin in the treatment of papulopustular rosacea","volume":"32","author":"Dereli","year":"2005","journal-title":"The Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0140|cit140","first-page":"135","article-title":"Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea","volume":"76","author":"Draelos","year":"2005","journal-title":"Cutis"},{"issue":"7","key":"10.1002\/14651858.CD003262.pub5-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archderm.134.7.884","article-title":"Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea","volume":"134","author":"Erdogan","year":"1998","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archderm.140.4.489","article-title":"Oral use of azithromycin for the treatment of acne rosacea","volume":"140","author":"Fernandez-Obregon","year":"2004","journal-title":"Archives of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0143|cit143","first-page":"585","article-title":"The face and mind evaluation study: An examination of the efficacy of rosacea treatment using physician ratings and patients' self-reported quality of life","volume":"4","author":"Fleischer","year":"2005","journal-title":"Journal of Drugs in Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD003262.pub5-BIB0144|cit144","first-page":"1410","article-title":"Clindamycin phosphate 1.2% and tretinoin 0.025% gel for rosacea: summary of a placebo-controlled, double-blind trial","volume":"11","author":"Freeman","year":"2012","journal-title":"Journal of Drugs in Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub5-BIB0145|cit145","first-page":"506","article-title":"Dimensions of the sample and power of clinical experimentation in a study of antibiotic therapy","volume":"108","author":"Frigerio","year":"1969","journal-title":"Bollettino Chimico Farmaceutico"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0002-9394(14)71750-7","article-title":"Efficacy of doxycycline and tetracycline in ocular rosacea","volume":"116","author":"Frucht-Pery","year":"1993","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1468-3083.2008.02822.x","article-title":"Clinical efficacy of tacrolimus in rosacea","volume":"23","author":"Garg","year":"2008","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1468-3083.2005.01144.x","article-title":"Has Helicobacter pylori eradication therapy any effect on severity of rosacea symptoms?","volume":"19","author":"Gedik","year":"2005","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD003262.pub5-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000257895","article-title":"Comparative study of triamcinolone acetonide and hydrocortisone 17-butyrate in rosacea with special regard to rebound phenomenon","volume":"152","author":"Go","year":"1976","journal-title":"Dermatologica"},{"issue":"14","key":"10.1002\/14651858.CD003262.pub5-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1001\/jama.1989.03420140014003","article-title":"New topical therapy for acne rosacea offers conspicuous improvement, no systemic effects","volume":"261","author":"Goldsmith","year":"1989","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2230.2004.01472.x","article-title":"Continuous 'microdose' isotretinoin in adult recalcitrant rosacea","volume":"29","author":"Hofer","year":"2004","journal-title":"Clinical & Experimental Dermatology"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0152|cit152","unstructured":"Irvine C Kumar P Marks R Isotretinoin in the treatment of rosacea and rhinophyma Acne and related disorders - Proceedings of an international symposium London 1988 301 5"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD003262.pub5-BIB0153|cit153","first-page":"AB19","article-title":"Combined effect of anti-inflammatory dose doxycycline and azelaic acid gel 15% in the treatment of rosacea","volume":"56","author":"Jackson","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1468-3083.2008.02589.x","article-title":"A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea","volume":"22","author":"Karabulut","year":"2008","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1385\/AO:37:2:077","article-title":"Effects of topical metranidazole in ocular rosacea","volume":"37","author":"Ko\u00e7ak-Altintas","year":"2005","journal-title":"Annals of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/09546630601121078","article-title":"Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea","volume":"18","author":"Laquieze","year":"2007","journal-title":"Journal of Dermatological Treatment"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2008.08496.x","article-title":"Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: An 8-week split-face clinical trial","volume":"158","author":"Lee","year":"2008","journal-title":"British Journal of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub5-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/archderm.142.8.1047","article-title":"Azelaic acid in the treatment of papulopustular rosacea: A systematic review of randomized controlled trials","volume":"142","author":"Liu","year":"2006","journal-title":"Archives of Dermatology"},{"issue":"68","key":"10.1002\/14651858.CD003262.pub5-BIB0159|cit159","first-page":"61","article-title":"Ivermectin cream in rosacea: Comparison with metronidazole gel","volume":"151","author":"Loo","year":"2004","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/ICO.0b013e31815c18d6","article-title":"Elevated expression and activation of matrix metalloproteinase 8 in tear fluid in atopic blepharoconjunctivitis","volume":"27","author":"M\u00e4\u00e4tt\u00e4","year":"2008","journal-title":"Cornea"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0161|cit161","first-page":"292","article-title":"Acne rosacea: Effectiveness of 532 nm laser on the cosmetic appearance of the skin","volume":"39","author":"Maxwell","year":"2010","journal-title":"Journal of Otolaryngology - Head & Neck Surgery"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0162|cit162","first-page":"25","article-title":"Randomized study of intense pulsed light and pulsed dye laser in the treatment of facial telangiectasia","volume":"40 Suppl 20","author":"Meekin","year":"2008","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD003262.pub5-BIB0163|cit163","first-page":"AB14","article-title":"The combination of metronidazole gel and sodium sulfacetamide cleanser is efficacious and well-tolerated by rosacea patients [P114]","volume":"58","author":"Mraz","year":"2008","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0164|cit164","first-page":"148","article-title":"Treatment of rosacea with tetracycline and metronidazole - A comparative study","volume":"35","author":"Nasir","year":"1985","journal-title":"Journal of the Pakistan Medical Association"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2133.1983.tb04003.x","article-title":"The relapse rate for rosacea after treatment with either oral tetracycline or metronidazole cream","volume":"109","author":"Nielsen","year":"1983","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0166|cit166","first-page":"459","article-title":"Topical PRK 124 (0.125%) lotion for improving the signs and symptoms of rosacea","volume":"8","author":"Ortiz","year":"2009","journal-title":"Journal of Drugs in Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub5-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1346-8138.2004.tb00566.x","article-title":"Efficiency of benzoyl peroxide-erythromycin gel in comparison with metronidazole gel in the treatment of acne rosacea","volume":"31","author":"Ozt\u00fcrkcan","year":"2004","journal-title":"Journal of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD003262.pub5-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cgh.2008.02.054","article-title":"Small intestinal bacterial overgrowth in rosacea: Clinical effectiveness of its eradication","volume":"6","author":"Parodi","year":"2008","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD003262.pub5-BIB0169|cit169","first-page":"P4","article-title":"Pulse-therapy with azithromycin in acne rosacea and peri-oral dermatitis: an open study","volume":"52","author":"Ruggero","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0170|cit170","first-page":"99","article-title":"Comparative evaluation by colorimetry and videocapillaroscopy of the efficacy of a cream composed of peptide of lupin and soya isoflavones on erythrocouperose","volume":"24","author":"Sainthillier","year":"2005","journal-title":"Nouvelles Dermatologiques"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bjo.79.1.42","article-title":"Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea","volume":"79","author":"Seal","year":"1995","journal-title":"British Journal of Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD003262.pub5-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1468-3083.2008.02609.x","article-title":"Rosacea\/acne rosacea: Efficacy of combination therapy of azithromycin and topical 0.1% tacrolimus ointment","volume":"22","author":"Sehgal","year":"2008","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"11","key":"10.1002\/14651858.CD003262.pub5-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/archderm.143.11.1369","article-title":"Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline","volume":"143","author":"Shanler","year":"2007","journal-title":"Archives of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0174|cit174","first-page":"177","article-title":"A pilot study of 5 percent permethrin cream versus 0.75 percent metronidazole gel in acne rosacea","volume":"56","author":"Signore","year":"1995","journal-title":"Cutis"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD003262.pub5-BIB0175|cit175","first-page":"AB17","article-title":"Evaluation of a topical treatment containing 8% sulfur and 2% resorcinol in the treatment of centrofacial rosacea","volume":"54","author":"Stoudemayer","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub5-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/lsm.20811","article-title":"Randomized controlled trial: Comparative efficacy for the treatment of facial telangiectasias with 532 nm versus 940 nm diode laser","volume":"41","author":"Tierney","year":"2009","journal-title":"Lasers in Surgery & Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1468-3083.2008.02781.x","article-title":"Short and limited effect of long-pulsed dye laser alone and in combination with photodynamic therapy for inflammatory rosacea","volume":"23","author":"Togsverd-Bo","year":"2009","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"12","key":"10.1002\/14651858.CD003262.pub5-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1046\/j.1365-4362.1997.00301.x","article-title":"Clarithromycin versus doxycycline in the treatment of rosacea","volume":"36","author":"Torresani","year":"1997","journal-title":"International Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0179|cit179","first-page":"299","article-title":"Treatment of papulopustular rosacea with sodium sulfacetamide 10%\/sulfur 5% emollient foam","volume":"8","author":"Trumbore","year":"2009","journal-title":"Journal of Drugs in Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0180|cit180","first-page":"441","article-title":"A split-face comparison study of pulsed 532-nm KTP laser and 595-nm pulsed dye laser in the treatment of facial telangiectasias and diffuse telangiectatic facial erythema","volume":"33","author":"Uebelhoer","year":"2007","journal-title":"Dermatologic Surgery"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0181|cit181","first-page":"381","article-title":"Metronidazole cream for the local treatment of rosacea","volume":"150","author":"Veien","year":"1988","journal-title":"Ugeskrift for Laeger"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0182|cit182","first-page":"94","article-title":"Treatment of rosacea fulminans with isotretinoin and topical alclometasone dipropionate","volume":"6","author":"Veraldi","year":"1996","journal-title":"European Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0183|cit183","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1358\/dof.2007.032.03.1083308","article-title":"Incyclinide. Dual MMP-2\/MMP-9 inhibitor treatment of acne treatment of rosacea","volume":"32","author":"Viera","year":"2007","journal-title":"Drugs of the Future"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11655-006-0277-1","article-title":"Effect of treatment of rosacea in females by Chibixiao Recipe in combination with minocycline and spironolactone","volume":"12","author":"Yu","year":"2006","journal-title":"Chinese Journal of Integrative Medicine"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0185|cit185","unstructured":"ACTRN12614000004662 A single-blind randomised controlled trial of topical Kanuka honey for the treatment of rosacea www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=365179"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0186|cit186","unstructured":"IRCT2014030416837N1 Effects of permethrin 5% topical gel in comparison with placebo on Demodex density in rosacea patients: a double-blind, randomized clinical trial www.irct.ir\/searchresult.php?keyword=&id=16837&number=1&prt=6008&total=10&m=1"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0187|cit187","unstructured":"NCT00560703 Efficacy and safety of COL-101 for the treatment of blepharitis in patients with facial rosacea clinicaltrials.gov\/ct2\/show\/NCT00560703"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0188|cit188","unstructured":"NCT00617903 A 12-week exploratory, multicenter, double-blind, vehicle-controlled study to investigate the efficacy and safety of topical azelaic acid 15% foam twice daily in patients with papulopustular rosacea clinicaltrials.gov\/ct2\/show\/NCT00617903"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0189|cit189","unstructured":"NCT00882531 Evaluation of the efficacy of isotretinoin versus placebo in terms of response rate among patients presenting papular-pustular rosacea resistant to standard therapy clinicaltrials.gov\/ct2\/show\/NCT00882531"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0190|cit190","unstructured":"NCT01125930 Investigation of the topical retinoid, Atralin gel 0.05% for the treatment of erythematotelangiectatic rosacea clinicaltrials.gov\/ct2\/show\/NCT01125930"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0191|cit191","unstructured":"NCT01451619 A randomized, double-blind, placebo-controlled, multi-center, parallel group study to assess the pharmacodynamics of MK-0524 in subjects with moderate to severe erythematotelangiectatic rosacea. (protocol No. 155) clinicaltrials.gov\/show\/NCT01451619"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0192|cit192","unstructured":"NCT01579084 Safety and tolerability of AGN-199201 in patients with erythema associated with rosacea clinicaltrials.gov\/show\/NCT01579084"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0193|cit193","unstructured":"NCT01614743 A double-blinded, randomized placebo controlled pilot study comparing the efficacy and safety of Incobotulinumtoxin A versus saline injections to the cheek region in patients with rosacea clinicaltrials.gov\/show\/NCT01614743"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0194|cit194","unstructured":"NCT01631656 Combination Finacea gel and vascular Nd:Yag laser therapy for mild to moderate rosacea clinicaltrials.gov\/show\/NCT01631656"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0195|cit195","unstructured":"NCT01735201 AGN-199201 for the treatment of erythema with rosacea clinicaltrials.gov\/show\/NCT01735201"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0196|cit196","unstructured":"NCT01740934 An eight-week, multi-site, double-blind, randomized, vehicle-controlled, parallel-group trial to evaluate the safety, tolerability, and effects of Anatabloc\u00ae cr\u00e8me in subjects with rosacea followed by an open-label extension clinicaltrials.gov\/show\/NCT01740934"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0197|cit197","unstructured":"EUCTR2006-001999-20-HU Assessment of the efficacy and safety of three concentration:1%, 0.3%, 0.1% of CD5024 cream once daily and CD5024 1% cream twice daily, versus its vehicle and versus metronidazole cream (Rozex\u00ae) in patients with papulopustular rosacea over 12 weeks apps.who.int\/trialsearch\/"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0198|cit198","unstructured":"EUCTR2006-003707-40-DE Activity of twice daily per os administration of CD06713 at 8mg versus its placebo during 4 weeks treatment, in patients with erythemato-telangiectatic rosacea apps.who.int\/trialsearch\/"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0199|cit199","unstructured":"EUCTR2006-007029-29-EE Non inferiority study of metronidazole 0.75% cream versus reference therapy in the local treatment of papulopustular rosacea apps.who.int\/trialsearch\/"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0200|cit200","unstructured":"EUCTR2008-003854-13-FR An investigator blind parallel group vehicle control study comparing the efficacy ad safety of CD 5024 1% cream with metronidazole 0.75% cream in subjects with papulopustular rosacea over 16 weeks treatment apps.who.int\/trialsearch\/"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0201|cit201","unstructured":"EUCTR2009-013111-35-DE Effect of CD08514 versus placebo, in patients presenting with type 1 rosacea, over an 8-week treatment apps.who.int\/trialsearch\/"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0202|cit202","unstructured":"EUCTR2010-018319-13-DE A double-blind, vehicle controlled, parallel group study assessing the activity of CD5024 1% cream in subjects with papulopustular rosacea over 12 weeks treatment apps.who.int\/trialsearch\/"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0203|cit203","unstructured":"EUCTR2010-021150-19-NL Doxycycline versus minocycline in the treatment of rosacea: a randomised controlled trial. - DoMino-study apps.who.int\/trialsearch\/"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0204|cit204","unstructured":"EUCTR2010-023566-43-DE No English title apps.who.int\/trialsearch\/"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0205|cit205","unstructured":"EUCTR2011-002057-65-DE Effect of CD08100\/02 3% gel versus placebo in subjects presenting with erythematotelangiectatic rosacea over a 4 week treatment period apps.who.int\/trialsearch\/"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0206|cit206","unstructured":"EUCTR2011-002058-30-DE Effect of CD08100\/02 3% gel versus placebo gel in subjects presenting with papulopustular rosacea over a 6-week treatment period apps.who.int\/trialsearch\/"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0207|cit207","unstructured":"EUCTR2011-004791-11-CZ Efficacy and safety of CD5024 1% cream versus metronidazole 0.75% cream in subjects with papulopustular rosacea over 16 weeks treatment, followed by a 36-week extension period apps.who.int\/trialsearch\/"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0208|cit208","unstructured":"EUCTR2012-001044-22-SE A multicenter, randomized, double-blind, vehicle-controlled, parallel group study to demonstrate the efficacy and assess the safety of CD07805\/47 gel 0.5%applied topically once daily in subjects with moderate to severe facial erythema of rosacea apps.who.int\/trialsearch\/"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0209|cit209","unstructured":"EUCTR2013-005083-26-DE Effect of CD07805\/47 gel in subjects presenting with flushing related to erythematotelangiectatic or papulopustular rosacea - Effect of CD07805\/47 gel in rosacea flushing apps.who.int\/trialsearch\/"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0210|cit210","unstructured":"IRCT2014010516079N1 Comparison of dapsone 5% topical gel with metronidazole 0.75% efficacy in combination with oral doxycycline in papulopustular rosacea apps.who.int\/trialsearch\/"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0211|cit211","unstructured":"JPRN-UMIN000008315 Clinical trial for development of topical rapamycin treatment for rosacea apps.who.int\/trialsearch\/"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0212|cit212","unstructured":"NCT00041977 A multicenter, randomized, double-blind, placebo-controlled, clinical trial to determine the effects of doxycycline hyclate 20 mg tablets [Periostat(R)] administered twice daily for the treatment of acne rosacea clinicaltrials.gov\/ct2\/show\/NCT00041977"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0213|cit213","unstructured":"NCT00436527 MetroGel 1% hydration study: a kinetic regression study clinicaltrials.gov\/show\/NCT00436527"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0214|cit214","unstructured":"NCT00495313 Determine the effects of COL-101 administered once daily with metronidazole topical gel, 1% versus doxycycline hyclate 100 mg administered once daily with metronidazole topical gel, 1% in patients with moderate to severe rosacea clinicaltrials.gov\/ct2\/show\/NCT00495313"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0215|cit215","unstructured":"NCT00621218 A pilot study to compare tretinoin gel, 0.05% to tretinoin gel vehicle when dosed once or twice daily in female subjects with classical rosacea clinicaltrials.gov\/ct2\/show\/NCT00621218"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0216|cit216","unstructured":"NCT00667173 A phase 2, multi-center, evaluator-blind, randomized, vehicle-controlled clinical study to assess the safety and efficacy of IDP-115 in the treatment of rosacea clinicaltrials.gov\/ct2\/show\/NCT00667173"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0217|cit217","unstructured":"NCT00697541 A phase II, single-center, two-way crossover relative systemic bioavailability study of Col-118 administered topically as a 0.18 % facial gel and brimonidine ophthalmic solution 0.2% administered to the eye in subjects with moderate to severe erythematous rosacea clinicaltrials.gov\/ct2\/show\/NCT00697541"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0218|cit218","unstructured":"NCT01016782 Multi-center, double-blind, randomized, vehicle-controlled, parallel group study of 0444 gel clinicaltrials.gov\/ct2\/show\/NCT01016782"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0219|cit219","unstructured":"NCT01134991 Pilot, randomized, double blind, placebo controlled, parallel group, dose range finding study, to evaluate the tolerability and safety of FXFM244 antibiotic foam and to monitor its clinical effect in moderate to severe rosacea patients clinicaltrials.gov\/ct2\/show\/NCT01134991"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0220|cit220","unstructured":"NCT01186068 A randomized, double-blind, vehicle-controlled, parallel-group study of the dose-response profile of V-101 cream in subjects with erythematous rosacea clinicaltrials.gov\/ct2\/show\/NCT01186068"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0221|cit221","unstructured":"NCT01257919 Investigator-blinded, randomized, cross-over, multiple dose phase I study on safety and pharmacokinetics of topically applied azelaic acid foam, 15% compared to azelaic acid gel, 15% in subjects with papulopustular rosacea clinicaltrials.gov\/show\/NCT01257919"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0222|cit222","unstructured":"NCT01308619 A multicenter, randomized, double-blind, placebo-controlled evaluation of rosacea-related inflammatory biochemical markers in the skin of adults with papulopustular rosacea treated with daily doxycycline 40 mg (30 mg immediate release \/ 10 mg delayed release beads) capsules clinicaltrials.gov\/show\/NCT01308619"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0223|cit223","unstructured":"NCT01513863 A randomized, double-blind, placebo controlled, parallel design, multi-site clinical study to compare the bioequivalence of two metronidazole 1% topical gel formulations in patients with moderate to severe rosacea clinicaltrials.gov\/show\/NCT01513863"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0224|cit224","unstructured":"NCT01555463 A randomized, double-blind, vehicle-controlled, multicenter, parallel-group clinical trial to assess the safety and efficacy of azelaic acid foam, 15% topically applied twice daily for 12 weeks in subjects with papulopustular rosacea clinicaltrials.gov\/show\/NCT01555463"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0225|cit225","unstructured":"NCT01659853 A multicenter, randomized, controlled, double-masked, crossover design study to compare efficacy and assess safety of CD07805\/47 gel 0.5% applied once daily vs azelaic acid gel 15% applied twice daily in subjects with erythema of rosacea clinicaltrials.gov\/show\/NCT01659853"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0226|cit226","unstructured":"NCT01784133 A phase 2, randomized, vehicle-controlled, double-blind, multicenter study to evaluate the safety and efficacy of three once-daily CLS001 topical gels versus vehicle administered for 12 weeks to subjects with papulopustular rosacea clinicaltrials.gov\/show\/NCT01784133"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0227|cit227","unstructured":"NCT01828177 A multicenter randomized evaluator-blinded vehicle-controlled parallel group evaluation of twice daily PDI-320 in comparison to its monads in adults with rosacea clinicaltrials.gov\/show\/NCT01828177"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0228|cit228","unstructured":"NCT01917539 Efficacy of Pulsed Light Therapy for Meibomian gland dysfunction and dry eye syndrome clinicaltrials.gov\/show\/NCT01917539"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0229|cit229","unstructured":"NCT01933464 An analysis of the effect of topical cromolyn sodium on rosacea-associated erythema clinicaltrials.gov\/show\/NCT01933464"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0230|cit230","unstructured":"NCT01993446 A randomized, double-blind, vehicle controlled study of the safety and efficacy of topical DRM02 in subjects with rosacea clinicaltrials.gov\/show\/NCT01993446"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0231|cit231","unstructured":"NCT02036229 A randomised, double blind, placebo controlled, half-face study to evaluate the effect of topical ivermectin cream 0.5% on demodicidosis clinicaltrials.gov\/ct2\/show\/NCT02036229"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0232|cit232","unstructured":"NCT02052999 An open label pilot study to evaluate the efficacy of PAC-14028 in the treatment of erythematotelangiectatic rosacea and papulopustular rosacea clinicaltrials.gov\/show\/NCT02052999"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0233|cit233","unstructured":"NCT02075671 Photodynamic therapy for papulopustular rosacea clinicaltrials.gov\/show\/NCT02075671"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0234|cit234","unstructured":"NCT02120924 A multicenter, double-blind, randomized, parallel-group, vehicle-controlled study to evaluate the safety and clinical equivalence of a generic azelaic acid gel, 15% and the reference listed Finacea\u00ae (azelaic acid) gel, 15% in patients with moderate facial rosacea clinicaltrials.gov\/show\/NCT02120924"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0235|cit235","unstructured":"NCT02132117 Safety and efficacy of AGN-199201 in patients with persistent erythema associated with rosacea clinicaltrials.gov\/show\/NCT02132117"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0236|cit236","unstructured":"NCT02144181 Evaluation of the safety and efficacy of the Ulthera\u00ae System for the treatment of signs and symptoms of erythematotelangiectatic rosacea clinicaltrials.gov\/show\/NCT02144181"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0237|cit237","unstructured":"NCT02147691 Finacea 15% and brimonidine 0.33% gel in the treatment of rosacea - a pilot study clinicaltrials.gov\/show\/NCT02147691"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0238|cit238","unstructured":"NCT02204254 Prospective, open label, randomized study comparing bipolar radiofrequency potentiated by infrared light to doxycycline in patient with papulopustular rosacea clinicaltrials.gov\/show\/NCT02204254"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2340\/00015555-0716","article-title":"Subjective disease perception and symptoms of depression in relation to healthcare-seeking behaviour in patients with rosacea","volume":"89","author":"Abram","year":"2009","journal-title":"Acta Dermato-Venereologica"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2133.2010.09894.x","article-title":"The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities","volume":"163","author":"Aksoy","year":"2010","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2165\/11530200-000000000-00000","article-title":"The role of tetracyclines in rosacea","volume":"11","author":"Alikhan","year":"2010","journal-title":"American Journal of Clinical Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-4632.2004.01958.x","article-title":"Therapeutic potential of azithromycin in rosacea","volume":"43","author":"Bakar","year":"2004","journal-title":"International Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1468-3083.2009.03132.x","article-title":"Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin","volume":"23","author":"Bakar","year":"2009","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0244|cit244","first-page":"16","article-title":"Oral therapy for rosacea","volume":"5","author":"Baldwin","year":"2006","journal-title":"Journal of Drugs in Dermatology"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD003262.pub5-BIB0245|cit245","first-page":"26","article-title":"A community-based study of the effectiveness of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) on quality of life and satisfaction with treatment in participants with rosacea","volume":"86","author":"Baldwin","year":"2010","journal-title":"Cutis"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jaad.2004.04.013","article-title":"Measurement of the severity of rosacea","volume":"51","author":"Bamford","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0247|cit247","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaad.2006.03.023","article-title":"Childhood stye and adult rosacea","volume":"55","author":"Bamford","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0248|cit248","first-page":"997","article-title":"The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results","volume":"159","author":"Basra","year":"2008","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0249|cit249","first-page":"419","article-title":"An epidemiological study of rosacea","volume":"69","author":"Berg","year":"1989","journal-title":"Acta Dermato-Venereologica"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0250|cit250","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/lsm.20621","article-title":"Rosacea treatment using the new-generation, high-energy, 595 nm, long pulse-duration pulsed-dye laser","volume":"40","author":"Bernstein","year":"2008","journal-title":"Lasers in Surgery & Medicine"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0251|cit251","doi-asserted-by":"crossref","unstructured":"Bero L Why the Cochrane risk of bias tool should include funding source as a standard item 2013 www.thecochranelibrary.com\/details\/editorial\/5655431\/Why-the-Cochrane-risk-of-bias-tool-should-include-funding-source-as-a-standard-item.html","DOI":"10.1002\/14651858.ED000075"},{"issue":"7","key":"10.1002\/14651858.CD003262.pub5-BIB0252|cit252","first-page":"838","article-title":"Optimal management of papulopustular rosacea: rationale for combination therapy","volume":"11","author":"Bhatia","year":"2012","journal-title":"Journal of Drugs in Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0253|cit253","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1540-9740.2003.03014.x","article-title":"Subantimicrobial dose doxycycline for acne and rosacea","volume":"2","author":"Bikowski","year":"2003","journal-title":"Skinmed"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0254|cit254","first-page":"251","article-title":"Rosacea: Where are we now?","volume":"3","author":"Bikowski","year":"2004","journal-title":"Journal of Drugs in Dermatology"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0255|cit255","first-page":"22","article-title":"Demystifying anti-inflammatory dose antibiotics for management of rosacea","volume":"April","author":"Bikowski","year":"2007","journal-title":"Practical Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0256|cit256","first-page":"35","article-title":"Laser and light therapies for acne rosacea","volume":"5","author":"Butterwick","year":"2006","journal-title":"Journal of Drugs in Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/1523-1747.ep12365600","article-title":"Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness","volume":"107","author":"Chren","year":"1996","journal-title":"Journal of Investigative Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0258|cit258","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1468-3083.2006.01991.x","article-title":"An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption","volume":"21","author":"Chu","year":"2007","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1540-9740.2005.03740.x","article-title":"Pimecrolimus for treatment of acne rosacea","volume":"4","author":"Crawford","year":"2005","journal-title":"Skinmed"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0260|cit260","first-page":"692","article-title":"The quality of life impact of acne and rosacea compared to other major medical conditions","volume":"13","author":"Cresce","year":"2014","journal-title":"Journal of Drugs in Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0261|cit261","first-page":"38","article-title":"Rosacea: A Review","volume":"34","author":"Culp","year":"2009","journal-title":"P & T"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0262|cit262","first-page":"16","article-title":"Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema","volume":"5","author":"Rosso","year":"2012","journal-title":"Journal of Clinical and Aesthetic Dermatology"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD003262.pub5-BIB0263|cit263","first-page":"1","article-title":"An evaluation of potential correlations between pathophysiologic mechanisms, clinical manifestations, and management of rosacea","volume":"91","author":"Rosso","year":"2013","journal-title":"Cutis"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0264|cit264","first-page":"277","article-title":"Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents","volume":"92","author":"Rosso","year":"2013","journal-title":"Cutis"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD003262.pub5-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.jaad.2013.06.009","article-title":"Management of facial erythema of rosacea: what is the role of topical \u03b1-adrenergic receptor agonist therapy?","volume":"69","author":"Rosso","year":"2013","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0266|cit266","first-page":"18","article-title":"Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, Part 3: A status report on systemic therapies","volume":"93","author":"Rosso","year":"2014","journal-title":"Cutis"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0267|cit267","first-page":"134","article-title":"Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea","volume":"93","author":"Rosso","year":"2014","journal-title":"Cutis"},{"issue":"7109","key":"10.1002\/14651858.CD003262.pub5-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub5-BIB0269|cit269","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009992.pub2","article-title":"Topical antifungal treatments for tinea cruris and tinea corporis","author":"El-Gohary","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0270|cit270","first-page":"120","article-title":"Results of a national rosacea patient survey: Common issues that concern rosacea sufferers","volume":"8","author":"Elewski","year":"2009","journal-title":"Journal of Drugs in Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0271|cit271","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1468-3083.2010.03751.x","article-title":"Rosacea - global diversity and optimized outcome: Proposed international consensus from the Rosacea International Expert Group","volume":"25","author":"Elewski","year":"2011","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"623","DOI":"10.18553\/jmcp.2014.20.6.623","article-title":"Current drug therapies for rosacea: a chronic vascular and inflammatory skin disease","volume":"20","author":"Feldman","year":"2014","journal-title":"Journal of Managed Care Pharmacy"},{"issue":"9","key":"10.1002\/14651858.CD003262.pub5-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1468-3083.2007.02455.x","article-title":"Standardized skin surface biopsy: method to estimate the Demodex folliculorum density, not to study the Demodex folliculorum prevalence","volume":"21","author":"Forton","year":"2007","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0274|cit274","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-3083.2011.04310.x","article-title":"Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link","volume":"26","author":"Forton","year":"2012","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-4362.2003.01780.x","article-title":"Measuring the severity of rosacea: A review","volume":"42","author":"Gessert","year":"2003","journal-title":"International Journal of Dermatology"},{"issue":"7650","key":"10.1002\/14651858.CD003262.pub5-BIB0276|cit276","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0277|cit277","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0278|cit278","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/014107689709000308","article-title":"Rosacea: Classification and treatment","volume":"90","author":"Jansen","year":"1997","journal-title":"Journal of the Royal Society of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0279|cit279","first-page":"449","article-title":"Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color","volume":"33","author":"Kawana","year":"2007","journal-title":"Dermatologic Surgery"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0280|cit280","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jaad.2009.08.020","article-title":"A pilot study in discrepancies in quality of life among three cutaneous types of rosacea","volume":"62","author":"Kini","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub5-BIB0281|cit281","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1468-3083.2009.03167.x","article-title":"Current topical and systemic approaches to treatment of rosacea","volume":"23","author":"Korting","year":"2009","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0282|cit282","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2133.2007.08028.x","article-title":"Mite-related bacterial antigens stimulate inflammatory cells in rosacea","volume":"157","author":"Lacey","year":"2007","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0283|cit283","first-page":"145","article-title":"Rosacea: The battle goes on","volume":"31","author":"Landow","year":"2005","journal-title":"Comprehensive Therapy"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD003262.pub5-BIB0284|cit284","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.jaad.2013.04.041","article-title":"Emerging therapies in rosacea","volume":"69","author":"Layton","year":"2013","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD003262.pub5-BIB0285|cit285","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1468-3083.2011.03995.x","article-title":"Clinical and laboratory study of ocular rosacea in northern Greece","volume":"25","author":"Lazaridou","year":"2011","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD003262.pub5-BIB0286|cit286","first-page":"11","article-title":"Photographic review of results from a clinical study comparing benzoyl peroxide 5%\/clindamycin 1% topical gel with vehicle in the treatment of rosacea","volume":"73","author":"Leyden","year":"2004","journal-title":"Cutis"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0287|cit287","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/09546630701485233","article-title":"The enigma of rosacea","volume":"18","author":"Marks","year":"2007","journal-title":"Journal of Dermatological Treatment"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0288|cit288","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/14764170902741311","article-title":"Quality of life and rosacea: Pulsed dye laser impact","volume":"11","author":"Menezes","year":"2009","journal-title":"Journal of Cosmetic & Laser Therapy"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0289|cit289","doi-asserted-by":"crossref","unstructured":"Moustafa F Lewallen RS Feldman SR The psychological impact of rosacea and the influence of current management options Journal of the American Academy of Dermatology 2014 973 80","DOI":"10.1016\/j.jaad.2014.05.036"},{"issue":"13","key":"10.1002\/14651858.CD003262.pub5-BIB0290|cit290","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s40265-014-0281-x","article-title":"Rosacea: new and emerging treatments","volume":"74","author":"Moustafa","year":"2014","journal-title":"Drugs"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub5-BIB0291|cit291","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1211\/jpp.59.8.0010","article-title":"Scavenging properties of metronidazole on free oxygen radicals in a skin lipid model system","volume":"59","author":"Narayanan","year":"2007","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0292|cit292","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jaad.2007.01.048","article-title":"A pilot quality-of-life instrument for acne rosacea","volume":"57","author":"Nicholson","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0293|cit293","first-page":"22","article-title":"Updated Physician's Guide to the Off-label Uses of Oral Isotretinoin","volume":"7","author":"Nickle","year":"2014","journal-title":"Journal of Clinical and Aesthetic Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0294|cit294","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.optm.2010.01.015","article-title":"Rosacea and its ocular manifestations","volume":"82","author":"Oltz","year":"2011","journal-title":"Optometry"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub5-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMcp042829","article-title":"Clinical practice. Rosacea","volume":"352","author":"Powell","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub5-BIB0296|cit296","first-page":"768","article-title":"Rosacea - S1 guideline","volume":"11","author":"Reinholz","year":"2013","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0297|cit297","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0298|cit298","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: Nonantibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0299|cit299","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0300|cit300","unstructured":"Sch\u00fcnemann H Bro\u017cek J Oxman A GRADE handbook for grading quality of evidence and strength of recommendation. Version 3.2 [updated March 2009] www.cc-ims.net\/gradepro 2009"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0301|cit301","first-page":"30","article-title":"The effect of pulsed dye laser on the dermatology life quality index in erythematotelangiectatic rosacea patients: an assessment","volume":"6","author":"Shim","year":"2013","journal-title":"Journal of Clinical and Aesthetic Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0302|cit302","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1517\/14740338.7.5.571","article-title":"The use and safety of doxycycline hyclate and other second-generation tetracyclines","volume":"7","author":"Sloan","year":"2008","journal-title":"Expert Opinion on Drug Safety"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0303|cit303","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","article-title":"Clinical, cellular, and molecular aspects in the pathophysiology of rosacea","volume":"15","author":"Steinhoff","year":"2011","journal-title":"Journal of Investigative Dermatology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD003262.pub5-BIB0304|cit304","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jaad.2013.04.045","article-title":"New insights into rosacea pathophysiology: a review of recent findings","volume":"69","author":"Steinhoff","year":"2013","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0305|cit305","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00003226-200401000-00020","article-title":"Oral tetracyclines for ocular rosacea: An evidence-based review of the literature","volume":"23","author":"Stone","year":"2004","journal-title":"Cornea"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0306|cit306","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.bjps.2006.11.022","article-title":"Treatment of rhinophyma with the Versajet Hydrosurgery System","volume":"61","author":"Taghizadeh","year":"2008","journal-title":"Journal of Plastic, Reconstructive & Aesthetic Surgery"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0307|cit307","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.12385","article-title":"An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes","volume":"169","author":"Tan","year":"2013","journal-title":"British Journal of Dermatology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD003262.pub5-BIB0308|cit308","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2013.04.043","article-title":"Rosacea: current state of epidemiology","volume":"69","author":"Tan","year":"2013","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0309|cit309","doi-asserted-by":"crossref","unstructured":"Tan J Liu H Leyden JJ Leoni MJ Reliability of Clinician Erythema Assessment grading scale Journal of the American Academy of Dermatology 2014 760 3","DOI":"10.1016\/j.jaad.2014.05.044"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0310|cit310","first-page":"71","article-title":"Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 4: a status report on physical modalities and devices","volume":"93","author":"Tanghetti","year":"2014","journal-title":"Cutis"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0311|cit311","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0733-8635(05)70147-9","article-title":"Acne and rosacea. New and emerging therapies","volume":"18","author":"Thiboutot","year":"2000","journal-title":"Dermatologic Clinics"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0312|cit312","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jaad.2008.10.014","article-title":"Oxidative stress and ferritin expression in the skin of patients with rosacea","volume":"60","author":"Tisma","year":"2009","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0313|cit313","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2288-6-52","article-title":"A system for rating the stability and strength of medical evidence","volume":"6","author":"Treadwell","year":"2006","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0314|cit314","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2340\/00015555-1204","article-title":"Rosacea treatment with intermediate-dose isotretinoin: follow-up with erythema and sebum measurements","volume":"92","author":"Uslu","year":"2012","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0315|cit315","unstructured":"van der Linden MM van Rappard DC Daams JG Sprangers MA Spuls PI de Korte J Health-related Quality of Life in Patients with Cutaneous Rosacea: A Systematic Review Acta Dermato-Venereologica"},{"issue":"5","key":"10.1002\/14651858.CD003262.pub5-BIB0316|cit316","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007628.pub3","article-title":"Interventions for female pattern hair loss","author":"Zuuren","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003262.pub5-BIB0317|cit317","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2133.2012.11148.x","article-title":"Lack of 'appropriately assessed' patient-reported outcomes in randomized controlled trials assessing the effectiveness of interventions for rosacea","volume":"168","author":"Zuuren","year":"2013","journal-title":"British Journal of Dermatology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD003262.pub5-BIB0318|cit318","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jaad.2013.04.042","article-title":"Ocular rosacea: common and commonly missed","volume":"69","author":"Vieira","year":"2013","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD003262.pub5-BIB0319|cit319","unstructured":"Walker C Webster G A multicenter, double-blind, randomized trial to evaluate long-term anti-inflammatory dose doxycycline (40 mg) therapy: Results of the lack of effect on bacterial flora Presented at: Fall Clinical Dermatology Conference. Las Vegas, NV, USA, 7-11 October 2006 2006"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0320|cit320","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archderm.1994.01690030091015","article-title":"Rosacea. Pathophysiology and treatment","volume":"130","author":"Wilkin","year":"1994","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003262.pub5-BIB0321|cit321","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003262.pub5-BIB0322|cit322","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jaad.2004.01.048","article-title":"Standard classification of rosacea: Report of the national rosacea society expert committee on the classification and staging of rosacea","volume":"50","author":"Wilkin","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD003262.pub5-BIB0323|cit323","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0324|cit324","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/jidsymp.2011.4","article-title":"Rosacea as a disease of cathelicidins and skin innate immunity","volume":"15","author":"Yamasaki","year":"2011","journal-title":"Journal of Investigative Dermatology. Symposium Proceedings \/ the Society for Investigative Dermatology, Inc. European Society for Dermatological Research"},{"issue":"12","key":"10.1002\/14651858.CD003262.pub5-BIB0325|cit325","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003262","article-title":"Interventions for rosacea","author":"Zuuren","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0326|cit326","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003262.pub2","article-title":"Interventions for rosacea","author":"Zuuren","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0327|cit327","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003262.pub3","article-title":"Interventions for rosacea","author":"Zuuren","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003262.pub5-BIB0328|cit328","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaad.2006.04.084","article-title":"Systematic review of rosacea treatments","volume":"56","author":"Zuuren","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003262.pub5-BIB0329|cit329","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003262.pub4","article-title":"Interventions for rosacea","author":"Zuuren","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003262.pub5\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T17:13:41Z","timestamp":1717866821000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003262.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,28]]},"references-count":329,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003262.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,28]]}}}